Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.360
-0.020 (-1.45%)
At close: Feb 4, 2025, 4:00 PM
1.390
+0.030 (2.21%)
After-hours: Feb 4, 2025, 7:17 PM EST
INZY's stock price has decreased by -74.39% in the past year and price targets may not have had time to catch up.
Inozyme Pharma Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$17.75
Upside
+1,205.15%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $43 → $30 | Buy | Maintains | $43 → $30 | +2,105.88% | Jan 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +708.82% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +1,076.47% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +1,076.47% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +929.41% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,591.18% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,591.18% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +929.41% | Oct 25, 2024 |
| Wedbush | Wedbush | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,002.94% | Sep 30, 2024 |
| Stifel | Stifel | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +1,076.47% | Sep 12, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $16 → $17 | Strong Buy | Initiates | $16 → $17 | +1,150.00% | Aug 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +929.41% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +1,591.18% | Aug 6, 2024 |
| Wedbush | Wedbush | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,002.94% | Jul 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +929.41% | Jul 2, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $14 | Buy | Initiates | $14 | +929.41% | May 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.